NFKB1 and cystic fibrosis: As TNF-α is a crucial element in the initiation and progression of inflammation in CF involved in NF-κB activation [31, 32], it was chosen as a suitable pro-inflammatory stimulant to investigate the anti-inflammatory effects of AZ, ETI and an AZ/ETI combination.